MARKET

BCPC

BCPC

Balchem Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

120.30
-1.49
-1.22%
Opening 12:46 05/24 EDT
OPEN
121.89
PREV CLOSE
121.79
HIGH
121.89
LOW
119.63
VOLUME
22.45K
TURNOVER
1.79M
52 WEEK HIGH
174.29
52 WEEK LOW
114.79
MARKET CAP
3.86B
P/E (TTM)
38.61
1D
5D
1M
3M
1Y
5Y
Declining Stock and Decent Financials: Is The Market Wrong About Balchem Corporation (NASDAQ:BCPC)?
With its stock down 16% over the past three months, it is easy to disregard Balchem (NASDAQ:BCPC). However, stock...
Simply Wall St. · 05/10 17:14
Balchem's Return on Invested Capital Insights
According to Benzinga Pro, during Q1, Balchem (NASDAQ:BCPC) earned $28.93 million, a 15.96% increase from the preceding quarter. Balchem also posted a total of $228.87 million in sales, a 7.38% increase since Q4.
Benzinga · 05/06 14:00
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's session saw 211 companies set new 52-week lows.
Benzinga · 05/03 16:20
--HC Wainwright Adjusts Balchem's Price Target to $152 from $155, Keeps Buy Rating
MT Newswires · 05/02 08:28
Blachem (BCPC) Q1 Earnings and Revenues Surpass Estimates
Blachem (BCPC) delivered earnings and revenue surprises of 21.92% and 8.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 04/29 12:25
Recap: Balchem Q1 Earnings
  Balchem (NASDAQ:BCPC) reported its Q1 earnings results on Friday, April 29, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Benzinga · 04/29 11:49
Balchem Q1 Adj. EPS $1.03 Beats $0.82 Estimate, Sales $228.90M Beat $207.69M Estimate
Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.82 by 25.61 percent. This is a 18.39 percent increase over earnings of $0.87 per share from the same
Benzinga · 04/29 11:10
Balchem Non-GAAP EPS of $1.03, revenue of $228.9M
Balchem press release (NASDAQ:BCPC): Q1 Non-GAAP EPS of $1.03. Revenue of $228.9M (+23.3% Y/Y).
Seekingalpha · 04/29 11:09
More
No Data
Learn about the latest financial forecast of BCPC. Analyze the recent business situations of Balchem Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

33.33%Strong Buy
66.67%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BCPC stock price target is 163.67 with a high estimate of 175.00 and a low estimate of 152.00.
High175.00
Average163.67
Low152.00
Current 120.30
EPS
Actual
Estimate
0.260.520.771.03
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 386
Institutional Holdings: 30.20M
% Owned: 94.02%
Shares Outstanding: 32.12M
TypeInstitutionsShares
Increased
97
609.25K
New
37
197.82K
Decreased
103
1.09M
Sold Out
28
101.07K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
+0.30%
Food & Tobacco
+0.40%
Key Executives
Chairman/President/Chief Executive Officer/Director
Theodore Harris
Chief Financial Officer
Martin Bengtsson
Senior Vice President/General Manager
James Hyde
Chief Accounting Officer
William Backus
General Counsel/Secretary
Mark Stach
Lead Director/Independent Director
John Televantos
Director
Kathleen Fish
Independent Director
David Fischer
Independent Director
Daniel Knutson
Independent Director
Joyce Lee
Independent Director
Perry Premdas
Independent Director
Matthew Wineinger
No Data
No Data
About BCPC
Balchem Corporation is engaged in developing, manufacturing, distributing and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health (HNH) segment provides human grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. HNH segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary, and savory manufacturers. Its Animal Nutrition & Health (ANH) segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry.

Webull offers kinds of Balchem Corporation stock information, including NASDAQ:BCPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCPC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BCPC stock methods without spending real money on the virtual paper trading platform.